Understanding CEP, DMF, CADIFA and ASMF

CEP (Certificate of Suitability to the Monographs of the European Pharmacopoeia)

  • Issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM).
  • Confirms that an Active Pharmaceutical Ingredient (API) complies with the European Pharmacopoeia (Ph. Eur.) monograph.
  • Simplifies regulatory approval in European countries.

DMF (Drug Master File)

  • A confidential document submitted to regulatory agencies (like the FDA in the U.S.) that provides detailed information about an API’s manufacturing, stability, and quality.
  • Helps drug manufacturers get approval without disclosing proprietary data to customers.

CADIFA (Certificado de Adequação de Insumo Farmacêutico Ativo)

  • Brazil’s equivalent of CEP, issued by ANVISA (Agência Nacional de Vigilância Sanitária).
  • Ensures the quality and compliance of an API for use in pharmaceuticals in Brazil.

ASMF (Active Substance Master File)

  • Similar to a DMF but used in the European Union (EU), UK, and other regions.
  • Submitted to regulatory agencies to protect confidential API manufacturing details while allowing reference in drug applications.

Each of these regulatory documents serves a similar purpose: ensuring the safety, quality, and compliance of APIs in different global markets. Let me know if you need more details on any of these!


Related Topics:

DMF FilingSOPAntibiotic Stewardship
BioequivalenceBiotechnologyBioinformatics

Leave a Comment